94671 ⎘
Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; One oxygen atom attached in position 2
MODULATORS OF EUKARYOTIC INITIATION FACTOR 2B, COMPOSITIONS AND METHODS
#2PESTICIDAL AND HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF
#3Bakuchiol derivatives, pharmaceutically acceptable salts thereof, and preparation method and use of the same
#4Neprilysin inhibitors
#5Modulators of eukaryotic initiation factor 2B, compositions and methods
#6ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#7Neprilysin inhibitors
#8HETEROCYCLIC COMPOUND
#9Neprilysin inhibitors
#10Modulators of eukaryotic initiation factor 2B, compositions and methods
#11Compositions for the treatment of pulmonary fibrosis
#12Neprilysin inhibitors
#13Androgen receptor modulators and methods for their use
#14Heterocyclic compound
#15ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS
#16ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#17Neprilysin inhibitors
#18Neprilysin inhibitors
#19Compositions for the treatment of pulmonary fibrosis
#20Tetradentate ligand, and production method therefor, synthetic intermediate thereof, and transition metal complex thereof
#21Heterocyclic compound
#22Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#23Neprilysin inhibitors
#24Neprilysin inhibitors
#25Heterocyclic compound
#26Neprilysin inhibitors
#27Compositions for the treatment of fibrosis and fibrosis-related conditions
#28Neprilysin inhibitors
#29Neprilysin inhibitors
#30Neprilysin inhibitors
#31Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
#32Ruthenium-catalyzed synthesis of biaryl compounds in water
#33Neprilysin inhibitors
#34Process for preparing heonone (meth)acrylate
#35Neprilysin inhibitors
#36Carboxamide compounds
#37Neprilysin inhibitors
#38Autotaxin inhibitors
#39Photosensitive compound, photosensitive resin, and photosensitive composition
#40Dual-acting oxazole antihypertensive agents
#41Neprilysin inhibitors
#42Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
#43Neprilysin inhibitors
#44Geranyl geranyl acetone (GGA) derivatives and compositions thereof
#45Amination of aryl alcohol derivatives
#46Heterocyclic compounds suitable for the treatment of dyslipidemia
#47Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's
#48Bicyclic aryl sphingosine 1-phosphate analogs
#49Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
#50Neprilysin inhibitors
#51Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
#52Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
#53Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies
#54Dual-acting oxazole antihypertensive agents
#55Sirtuin 1 and the treatment of neurodegenerative diseases
#56New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
#57Compounds, compositions, and methods for the treatment of synucleinopathies
#58Bicyclic aryl sphingosine 1-phosphate analogs
#59Polycyclic acid compounds useful as CRTH2 antagonists and antiallergic agents
#60COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
#61Use of compounds and compositions for the treatment of amyloid diseases
#62Histamine-3 receptor antagonists
#63Sulphones which modulate the action of gamma secretase
#64Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
#65Neurotrophin production/secretion promoting agent
#66COMPOUNDS TO TREAT AMYLOIDOSIS AND PREVENT DEATH OF BETA-CELLS IN TYPE 2 DIABETES MELLITUS
#67Compounds, Compositions, and Methods
#68Compounds, compositions and methods for the treatment of synucleinopathies
#69Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
#70Sulphones which modulate the action of gamma-secretase
#71Therapeutic amide derivatives
#723-phenylpropionic acid derivatives
#73Methods for inhibition of angiogenesis
#74Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
#75Antibacterial compounds
#76Histone deacetylase inhibitors
#773-phenylpropionic acid derivatives
#78Antibacterial agents
#79Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
#80Azole compounds
#81N-Aryl-2-cyanooxazolidinones and their derivatives
#82Method for the synthesis of amides and related products from esters or ester-like compounds
#835-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof